Deltec Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,132
Closed -$556K 166
2024
Q4
$556K Buy
+2,132
New +$633K 0.11% 106
2016
Q4
Sell
-13,100
Closed -$2.19M 162
2016
Q3
$2.19M Buy
13,100
+5,100
+64% +$862K 0.49% 55
2016
Q2
$1.22M Buy
8,000
+4,000
+100% +$622K 0.31% 72
2016
Q1
$600K Buy
+4,000
New +$594K 0.15% 98
2014
Q2
Sell
-4,700
Closed -$580K 147
2014
Q1
$580K Sell
4,700
-300
-6% -$36.4K 0.13% 94
2013
Q4
$570K Hold
5,000
0.14% 93
2013
Q3
$560K Hold
5,000
0.15% 91
2013
Q2
$493K Buy
+5,000
New +$519K 0.15% 90

Other funds holding AMGN

Deltec Asset Management's AMGN Position: Q1 2025 in Review

Deltec Asset Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2,132 shares — an estimated $556K sold.

Deltec Asset Management first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $2.19M in Q3 2016. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Deltec Asset Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Deltec Asset Management sold 2,132 Amgen shares in Q1 2025, an estimated $556K.
  • Deltec Asset Management first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
  • Deltec Asset Management's Amgen position peaked at $2.19M in Q3 2016.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Deltec Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.